About Perturb Bio Inc.
Perturb Bio is a company developing a multimodal cardiac-safety dataset (CMRD) using human iPSC-cardiomyocytes for pharmaceutical cardiac safety teams. The dataset includes paired Cell Painting and DRUG-seq data across ~80 compounds and multiple iPSC-CM lines, with a focus on post-2024 FDA NMEs and patient-derived lines.
Development of a multimodal cardiac-safety dataset (CMRD) using human iPSC-cardiomyocytesCalibration program for proprietary compounds with multimodal mechanism profilingCRISPR or small-molecule perturbation screens with end-to-end wet-lab and analysisAI-driven experimental design and iterative testing in a robotic cloud labMultimodal Cell Painting and DRUG-seq analysis on matched parallel arms
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to Perturb Bio Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.